Joseph Parrish
Interventional Cardiology · Pinehurst, NCNPI 1518902584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,083 and has fallen 85.8% since, to $154 in 2021. That places this record below the midpoint for interventional cardiology clinicians in NC, where the typical reported total is $5,390.
Across 82 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$150
- Abiomed$125
- Boston Scientific$124
- Opsens Inc.$117
- Johnson & Johnson$112
- AstraZeneca$91
- plus $752 from 20 others
What the payments were for
- Food & beverage$1,44898%
- Education$242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 7 | $150 |
| Abiomed | 1 | $125 |
| Boston Scientific | 1 | $124 |
| Opsens Inc. | 1 | $117 |
| Johnson & Johnson | 11 | $112 |
| AstraZeneca | 7 | $91 |
| Novartis | 7 | $90 |
| Amgen | 6 | $78 |
| E.r. Squibb & Sons, L.L.C. | 5 | $69 |
| Sanofi-aventis U.S. LLC | 5 | $67 |
| Boehringer Ingelheim | 4 | $65 |
| Amarin Pharma, Inc. | 4 | $56 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $54 |
| Pfizer | 4 | $51 |
| Abbott | 2 | $37 |
| Atricure, Inc. | 2 | $31 |
| Chiesi USA, Inc. | 2 | $24 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| Edwards Lifesciences | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $14 |
| Braemar Manufacturing, LLC | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Livanova USA, Inc. | 1 | $12 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$125
- GENERAL - STENTS$124
- OptoWire$117
- OptoMonitor$117
How this compares
$1,472 in reported general payments places this provider in the 15th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Other interventional cardiology in Pinehurst
- Patrick SimpsonPinehurst$579K
- Steven FilbyPinehurst$442K
- William HarrisPinehurst$15K
- Peter DuffyPinehurst$12K
- George AdamsGarner$4.1M
- Paul MahoneyGreenville$1.7M
- Ravish SacharRaleigh$1.6M
- Ronald UszenskiMooresville$495K
- Oluseun AlliCharlotte$485K
- Matthew CavenderChapel Hill$453K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.